L-glutamine for sickle cell disease: more than reducing redoxANNALS OF HEMATOLOGYIF2.42022-05-1416PRE
L-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope?BLOOD REVIEWSIF5.72022-05-0126PRE
Low diagnostic yield of repeat blood cultures in adult haematologic malignancy patients with persistent neutropenic feverJOURNAL OF INTERNAL MEDICINEIF9.22020-10-214PREAI
STREPTOCOCCUS AGALACTIAE ENDOCARDITIS: AN UNUSUAL COMPLICATION OF GOOD'S SYNDROMECHESTIF8.62020-10-010OAAI
SPONTANEOUS PNEUMOMEDIASTINUM AND MULTIPLE PNEUMOTHORACES: AN UNUSUAL PRESENTATION OF BLEOMYCIN-RELATED LUNG TOXICITYCHESTIF8.62020-10-011OAAI
A CASE OF RUPTURED MYCOTIC ANEURYSM AFTER DISSEMINATED MYCOBACTERIUM BOVIS INFECTIONCHESTIF8.62020-10-011OAAI
MORTALITY AFTER CATHETER-DIRECTED THROMBOLYSIS AND SYSTEMIC THROMBOLYTICS IN PATIENTS WITH SADDLE PULMONARY EMBOLISMCHESTIF8.62020-10-010OAAI
A contemporary review ofClostridioides difficileinfections in patients with haematologic diseasesJOURNAL OF INTERNAL MEDICINEIF9.22020-09-259OAAI
High incidence of healthcare facility-acquiredClostridium difficileinfections in chronic opioid usersJOURNAL OF INTERNAL MEDICINEIF9.22020-06-234OAAI
Low Incidence of Hospital-Onset Clostridium difficile Infection in Sickle Cell DiseaseNEW ENGLAND JOURNAL OF MEDICINEIF78.52019-02-2811OAAI